|

Parkinson's Disease Clinical Trials in San Jose, CA

22 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 216 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 216 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 316 mi
Pimavanserin vs. Quetiapine for Treatment of Parkinson's PsychosisPhase 416 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—16 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—16 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 416 mi
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's DiseaseN/A17 mi
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy VolunteersPhase 1/217 mi
Use of CereGate Therapy for Freezing of Gait in PDN/A22 mi
Ketamine for Veterans With Parkinson's DiseasePhase 242 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 242 mi
Parkinson's Foundation PD GENEration Genetic Registry—42 mi
Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)Phase 242 mi
Parkinson Progression Marker Initiative Online (PPMI Online)—42 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—42 mi
Psilocybin Therapy for Depression in Parkinson's DiseasePhase 242 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 342 mi
Safety and Usability of the Cionic Neural Sleeve for Parkinson's DiseaseN/A42 mi
Understanding Motivation in Parkinson's Patients Through NeurophysiologyN/A42 mi
Blood Flow Restriction and Exercise in Parkinson's DiseaseN/A42 mi
Exercise for Cognitive Excellence in Parkinson's DiseaseN/A42 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.